Developing improved therapeutic uses for existing molecules

Developing improved therapeutic uses for existing molecules

Strong product pipeline

Medac Pharma, Inc. is a specialty pharmaceutical company based in Chicago, Illinois. We are focused on the development and commercialization of treatments for autoimmune diseases and oncology. By forming new partnerships and leveraging our business development efforts, we have the opportunity to make significant medical advancements that can help patients live better lives.

Medac Pharma, Inc., founded in 2012, is a wholly owned subsidiary of Medexus Pharmaceuticals, a Canadian-based pharmaceutical company formed in October 2018 through a transformative acquisition involving Pediapharm and Medexus, Inc. By combining Pediapharm’s Canadian pediatric specialty pharmaceutical business with the Canadian diversified specialty pharmaceutical business of Medexus and the U.S. autoimmune specialty pharmaceutical business of Medac Pharma, the Acquisition creates a leading North American commercial-stage specialty pharmaceutical company strategically positioned for future growth.